Gender differences in utilization of colorectal cancer screening

Journal of Medical Screening

Volumn 12, Issue 1, 2005, Pages 20-27

  Wardle, Jane ^a   Miles, Anne ^a   Atkin, Wendy ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST MARK S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CLINICAL TRIAL; COLORECTAL CANCER; DEMOGRAPHY; FEMALE; FLEXIBLE SIGMOIDOSCOPY; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MULTICENTER STUDY; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SEX DIFFERENCE; SIGMOIDOSCOPY; SOCIOECONOMICS; UNITED KINGDOM;

ATTITUDE TO HEALTH; COLORECTAL NEOPLASMS; FEMALE; GREAT BRITAIN; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SEX DISTRIBUTION; SIGMOIDOSCOPY;

EID: 15944419926     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1258/0969141053279158     Document Type: Article

References (56)

1. Edwards BK, Howe HL, Ries LAG, et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on the US cancer burden. Cancer 2002;94:2766-92
2. Parkin D, Bray F, Devesa S. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37:4-66
3. American Cancer Society. Cancer Facts and Figures 2003. Atlanta, American Cancer Society, 2003
4. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7
5. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1407-71
6. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71
7. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-7
8. Newcomb PA, Storer BE, Morimoto LM, Templeton A, Potter JD. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Int 2003;95:622-5
9. Beier ME, Ackerman PL. Determinants of health knowledge: an investigation of age, gender, abilities, personality, and interests. J Pers Soc Psychol 2003;84:439-48
10. Brunswick N, Wardle J, Jarvis MJ. Public awareness of warning signs for cancer in Britain. Cancer Causes Control 2001;12:33-7
11. Wardle J, Waller J, Brunswick N, Jarvis MJ. Awareness of risk factors for cancer among British adults. Public Health 2001;115:173-4
12. Helzlsouer KJ, Ford DE, Hayward RS, Midzenski M, Perry H. Perceived risk of cancer and practice of cancer prevention behaviors among employees in an oncology center. Prev Med 1994;23:302-8
13. Hay JL, Ostroff JS, Cruz GD, LeGeros RZ, Kenigsberg H, Franklin DM. Oral cancer risk perception among participants in on oral cancer screening program. Cancer Epidemiol BiomaLupusrkers Prev 2002;11:155-8
14. Lipkus IM, Rimer BK, Lyna PR, Pradhan AA, Conaway M, Woods-Powell CT. Colorectal screening patterns and perceptions of risk among African-American users of a community health center. J Community Health 1996;21:409-27
15. Courtenay WH, McCreary DR, Merighi JR. Gender and ethnic differences in health beliefs and behaviours. J Health Psychol 2002;7:219-31
16. Furnham A, Kirkcaldy B. Age and sex differences in health beliefs and behaviours. Psychol Rep 1997;80:63-6
17. Wardle J, Haase AM, Steptoe A, Nillapun M, Jongwutiwes K, Bellisle F. Gender differences in food choice: the contribution of health beliefs and dieting. Ann Behav Med 2003;27:107-16
18. Airey C, Bruster S, Erens B, Lilley SJ, Pickering K, Pitson L. The National Surveys of NHS Patients: General Practice 1998. London: NHS Executive, 1999
19. Banks I. No man's land: men, illness, and the NHS. BMJ 2001;323:1058-60
20. Corney RH. Sex differences in general practice attendance and help seeking for minor illness. J Psychosom Res 1990;34:525-34
21. Kroenke K, Spitzer RL. Gender differences in the reporting of physical and somatoform symptoms. Psychosom Med 1998;60:150-5
22. Behavioral Risk Factors and Surveillance Survey. Centres for Disease Control website. Date accessed: 26-1-2004
23. Sandman D, Simantov E, An C. Out of Touch: American men and the health care system. New York: The Commonwealth Fund, 2000
24. Barsky AJ, Peekna HM, Borus JF. Somatic symptom reporting in women and men. J Gen Intern Med 2001;16:266-75
25. Verbrugge LM. The twain meet: empirical explanations of sex differences in health and mortality. J Health Soc Behov 1989;30:282-304
26. MacIntyre S, Hunt K, Sweeting H. Gender differences in health: are things really as simple as they seem? Soc Sci Med 1996;42:617-24
27. Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 2002;50:29-32
28. Tazi MA, Faivre J, Dassonville F, Lamour J, Milan C, Durand G. Participation in faecal occult blood screening for colorectal cancer in a well defined French population: results of five screening rounds from 1988 to 1996. J Med Screen 1997;4:147-51
29. Rasmussen M, Kronborg O, Fenger C, Jorgensen OD. Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult-II in screening for colorectal cancer. A randomized study. Scand. J Gastroenterol. 1999;34:73-8
30. Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 2004; 100:2093-103
31. Senore C, Segnan N, Rossini P, et al. Screening for colorectal cancer by once only sigmoidoscopy: a feasibility study in Turin, Italy. J Med Screen 1996;3:72-8
32. UK Flexible Sigmoidoscopy Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 2002;359:1291-300
33. Myers RE, Ross E, Jepson C, et al. Modeling adherence to colorectal cancer screening. Prev Med 1994;23:142-51
34. Brawarsky P, Brooks DR, Mucci LA. Correlates of colorectal cancer testing in Massachusetts men and women. Prev Med 2003;36:659-68
35. Jernigan JC, Trauth JM, Neal Ferguson D, Cartier-Ulrich C. Factors that influence cancer screening in older African American men and women: focus group findings. Family Community Health 2001;24:27-33
36. Nadel MR, Blackman DK, Shapiro JA, Seeff LC. Are people being screened for colorectal cancer as recommended? Results from the National Health Interview Survey. Prev Med 2002;35:199-206
37. Wardle J, Sutton S, Williamson S, et al. Psychosocial influences on older adults' interest in participating in bowel cancer screening. Prev Med 2000;31:323-34
38. Atkin WS, Cooke L, Cuzick J, Edwards R, Northover JMA, Wardle J. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 2002;359:1291-3000
39. Atkin W, Edwards R, Wardle J, et al. Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen 2001;8:137-44
40. Idler EL, Benyamini Y. Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav 1997;21-37
41. Sutton S, Bickler G, Sancho-Aldridge J, Saidi G. Prospective study of predictors of attendance for breast screening in inner London. J Epidemiol Commun Health 1994;48:65-73
42. Sutton S, Wardle J, Taylor T, et al. Predictors of attendance in the United Kingdom flexible sigmoidoscopy screening trial. J Med Screen 2000;7:99-104
43. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173-82
44. Herold AH, Riker AI, Warner EA, et al. Evidence of gender bias in patients undergoing flexible sigmoidoscopy. Cancer Detect Prev 1997;21:141-7
45. Shapiro JA, Seeff LC, Nadel MR. Colorectal cancer-screening tests and associated health behaviours. Am J Prev Med 2001;21:132-7
46. Hart AR, Eaden J, Barnett S, de Bono AM, Mayberry JF. Colorectal cancer prevention. An approach to increasing compliance in a faecal occult blood test screening programme. J Epidemiol Community Health 1998;52:818-20
47. Cancer Research UK. Perceptions of risk survey Unpublished Report, 2004
48. Office for National Statistics, Social Survey Division. Living in Britain: Results from the 2001 General Household Survey. London: The Stationery Office, 2002
49. Lewis SF, Jensen NM. Screening sigmoidoscopy. Factors associated with utilization. J Gen Intern Med 1996;11:542-4
50. McCarthy BD, Moskowitz MA. Screening flexible sigmoidoscopy: patient attitudes and compliance. J Gen Intern Med 1993;8:120-5
51. Wardle J, Williamson S, McCaffery K, et al. Increasing attendance at colorectal cancer screening: testing the efficacy of a mailed, psychoeducational intervention in a community sample of older adults. Health Psychol 2003;22:99-105
52. Frew E, Wolstenholme J, Whynes D. Moss population screening for colorectal cancer: factors influencing subjects' choice of screening test. J Health Serv Res Policy 2001;6:85-91
53. Pye G, Jackson J, Thomas WM, Hardcastle JD. Comparison of coloscreen self-test and haemoccult faecal occult blood tests in the detection of colorectal cancer in symptomatic patients. Br J Surg 1990;77:630-1
54. Farraye FA, Wong M, Hurwitz S, et al. Barriers to endoscopic colorectal cancer screening: are women different from men? Am J Gastroenterol 2004;99:341-9
55. Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 2004;100:2093-103
56. Miles A, Cockburn J, Smith RA, Wardle J. A perspective from countries using organized screening programs. Cancer 2004;101:1201-13